Table 2 Surgical approach and outcomes
Variables | Pre-TG18 group (2013–2017, n = 17) | Post-TG18 group (2018–2020, n = 27) | P-value |
|---|---|---|---|
Open surgery/laparoscopic surgery | 8 (47.1%)/ 9 (52.9%) | 3 (11.1%)/ 24 (88.9%) | 0.007* |
Open conversion rate | 3 (33.3%) | 3 (12.5%) | 0.167 |
SC | 4 (23.5%) | 11 (40.7%) | 0.241 |
Open SC/laparoscopic SC | 4 (100.0%)/ 0 | 1 (9.1%)/ 10 (90.9%) | 0.001* |
Open conversion rate | 0 | 3 (30.0%) | |
Operative time, min [IQR] | 137 [97–181] | 125 [111–148] | 0.373 |
Blood loss, mL [IQR] | 110 [3–305] | 45 [15–100] | 0.353 |
Postoperative hospital stay, days [IQR] | 10 [4–13] | 8 [4–20] | 0.515 |
Wound infection | 1 (5.8%) | 1 (3.7%) | 0.736 |
Subhepatic abscess | 1 (5.8%) | 2 (7.4%) | 0.845 |
Bile leakage | 0 | 0 | |
Common bile duct injury | 0 | 0 |